Long-term diabetes progress after Supaglutide treatment
Part of Hormones & metabolism clinical trials.
This study follows up with people who were in an earlier Supaglutide trial to see how their diabetes is doing after treatment. It helps researchers understand if the medication's effects last over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in a previous study of Supaglutide (a diabetes medication).
- Your HbA1c (average blood sugar over 2–3 months) must be 7.0% or lower.
- Your blood sugar should have been stable during your last treatment period, as judged by your doctor.
- You need to agree to keep a healthy diet and exercise routine and check your blood sugar at home regularly.
- You must be willing to sign a consent form and follow the study plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, BGM0504, for people recently diagnosed with type 2 diabetes who also have obesity. It aims to see if the drug can help control blood sugar and support weight loss.
This trial follows up with people who previously took part in the GLUTADIAB study to see how their health changes over time. It helps researchers learn more about diabetes and its long-term effects.
This study looks at how semaglutide (a medication for type 2 diabetes or weight management) affects your heart, kidneys, and overall metabolic health over time. It uses medical records from LMC endocrinology clinics to track real-world outcomes.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study tests a new medication called bofanglutide in adults with type 2 diabetes who are currently taking metformin. The medication works similarly to a hormone that helps control blood sugar, and the study aims to see if it can help lower blood sugar levels and manage weight better.
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
Hear when a new Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.